CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
25.41
-0.45 (-1.74%)
At close: Jun 16, 2025, 3:59 PM
25.46
0.20%
After-hours: Jun 16, 2025, 04:35 PM EDT
-1.74% (1D)
| Bid | 25 |
| Market Cap | 1.94B |
| Revenue (ttm) | 662K |
| Net Income (ttm) | -105.56M |
| EPS (ttm) | -1.5 |
| PE Ratio (ttm) | -16.94 |
| Forward PE | -15.57 |
| Analyst | Buy |
| Ask | 28 |
| Volume | 638,304 |
| Avg. Volume (20D) | 1,384,546 |
| Open | 26.13 |
| Previous Close | 25.86 |
| Day's Range | 25.03 - 26.13 |
| 52-Week Range | 14.80 - 40.47 |
| Beta | 0.86 |
About CGON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+4.72%
CG Oncology shares are trading higher after JP Mor...
Unlock content with
Pro Subscription
1 month ago
+25.03%
CG Oncology shares are trading higher after the company announced that cretostimogene grenadenorepvec monotherapy data was presented at the American Urological Association Annual Meeting.
